# Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

> **NCT02180997** · PHASE1 · COMPLETED · sponsor: **Jeil Pharmaceutical Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- LUTS
- Benign Prostatic Hyperplasia
- Overactive Bladder

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** Solifenacin
- **DRUG:** Tamsulosin and solifenacin

## Key facts

- **NCT ID:** NCT02180997
- **Lead sponsor:** Jeil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02180997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02180997, "Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02180997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*